Sector in which the organization works:
Short description of the organization and its work to control and eliminate NTDs
FHI 360 programs work to reduce the prevalence of neglected tropical diseases (NTDs) that cause preventable death and severe long-term disability in resource-limited countries, and that disproportionally affect women and children. These efforts are complemented by specialized projects that support administration of preventative and curative medicines, strengthen disease surveillance, and provide national NTD teams with training, technical assistance and logistical support. FHI 360 administers two projects funded by the U.S. Agency for International Development (USAID) to control and eliminate NTDs. END in Africa and END in Asia support USAID's goals to reduce the global prevalence of:
- Lymphatic filariasis (elephantiasis)
- Onchocerciasis (river blindness)
- Schistosomiasis (snail fever)
- Three soil-transmitted helminths (hookworm, roundworm and whipworm)
- Trachoma (blinding eye infection).
As the lead implementing agency for these projects, FHI 360 works closely with USAID and END program partners, sub-grantees and national ministries of health, overseeing the successful rollout and implementation of country-led activities including:
- Coordination of drug supply and delivery
- Implementation of mass drug administration and other in-country NTD control activities
- Capacity building to strengthen program financial management and operations
- Monitoring and evaluation of program impact and financial management processes
- Knowledge management and dissemination.